Cassava Sciences, Inc. - Common Stock (NQ:SAVA)
All News about Cassava Sciences, Inc. - Common Stock
Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data
March 25, 2025
Via GlobeNewswire
Cassava Sciences Licenses Simufilam Method of Treatment Patent
February 27, 2025
Via GlobeNewswire
Via TheNewswire.com